Wholesale of pharmaceutical and medical goods
FARMACAN AS
Revenue 2024
NOK 889,000
Operating profit
NOK −290,000
Equity
NOK −265,000
Incorporated
2020
Share capital
NOK 30,000
Key figures · 2024
Current ratio
0.32
Equity ratio
-50.4%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | -32.6% | |
| Net margin (%%) | -32.6% | |
| Return on assets (%%) | -55.1% | |
| Likviditet | ||
| Current ratio | 0.32 | |
| Working capital | −537k | |
| Soliditet | ||
| Equity ratio (%%) | -50.4% | |
| Debt-to-equity ratio | -2.99 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.